| |
| |
|
| Insider
Information: |
Roth David |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
79 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
79 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Infinity Pharmaceuticals Inc |
INFI |
Officer |
|
0 |
2014-01-31 |
79 |
Premium* |
|
|
Syros Pharmaceuticals, Inc. |
SYRS |
|
2024-04-03 |
0 |
2019-02-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SYRS |
Syros Pharmaceuticals, In... |
Chief Medical Officer |
• – – |
2024-04-03 |
4 |
AS |
$4.95 |
$51,732 |
D/D |
(10,451) |
0 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Medical Officer |
• – – |
2024-04-02 |
4 |
AS |
$4.98 |
$747 |
D/D |
(150) |
10,451 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Medical Officer |
• – – |
2024-04-01 |
4 |
D |
$5.12 |
$24,228 |
D/D |
(4,732) |
10,601 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Medical Officer |
• – – |
2024-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,333 |
15,333 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Medical Officer |
• – – |
2023-12-12 |
4 |
AS |
$4.95 |
$31,121 |
D/D |
(6,287) |
0 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Medical Officer |
• – – |
2023-12-06 |
4 |
AS |
$3.95 |
$24,834 |
D/D |
(6,287) |
6,287 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Medical Officer |
• – – |
2023-11-01 |
4 |
D |
$2.22 |
$13,988 |
D/D |
(6,301) |
12,574 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Medical Officer |
• – – |
2023-10-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,875 |
18,875 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Medical Officer |
• – – |
2023-07-31 |
4 |
AS |
$3.95 |
$29,025 |
D/D |
(7,348) |
0 |
0 |
% |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Medical Officer |
• – – |
2022-04-01 |
4 |
D |
$1.12 |
$30,555 |
D/D |
(27,281) |
59,719 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Chief Medical Officer |
• – – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
87,000 |
87,000 |
0 |
- |
|
| INFI |
Infinity Pharmaceuticals ... |
Chief Medical OfficerOfficer |
• – – |
2014-01-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
79 |
|
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
